Independent researchers and clinical trial participants will gain greater access to data under an initiative announced by Pfizer. "We are impressed to see how active patients are individually to manage and understand their disease," Pfizer research chief Mikael Dolsten said. "... In patient foundations, a tremendous, great job is made to contribute to the advance of care."
Published in Brief: